Sinco Pharmaceuticals Holdings Limited (HKG:6833)

HKG:6833 Revenue

Sinco Pharmaceuticals Holdings had revenue of 1.03B CNY in the half year ending June 30, 2026, a decrease of -32.38%. This brings the company's total for the last twelve months to 1.92B, down -22.85% year-over-year. In the year 2025, Sinco Pharmaceuticals Holdings had annual revenue of 2.08B, down -26.11%. That makes Sinco Pharmaceuticals Holdings the 14,929th largest company in the world by revenue and 882nd in Hong Kong.

• Revenue (ttm): 1.92B CNY
• Revenue Growth: -22.85%
• P/S Ratio: 0.13
• Revenue / Employee: 7.48M CNY
• Employees: 257
• Market Cap: 284.60M HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Segment

Chart

• Sale of Imported Pharmaceutical Products 2.06B 99.0%
• Medical Beauty Services 21.03M 1.0%

Fiscal year ended Dec 31, 2025 See the full HKG:6833 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.08B	-736.75M	-26.11%
Dec 31, 2024	2.82B	281.26M	11.07%
Dec 31, 2023	2.54B	268.56M	11.82%
Dec 31, 2022	2.27B	247.45M	12.23%
Dec 31, 2021	2.02B	-25.75M	-1.26%

Data Source: S&P Global Market Intelligence Last updated: Sep 18, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 19, 2026

Data Sources Report a data error